A Novel Association Between Human Papillomavirus and Thyroid Eye Disease

I Garg, BI Meyer, RA Gallo, ST Wester, D Pelaez - medRxiv, 2024 - medrxiv.org
Context: Thyroid eye disease (TED) is an autoimmune disease characterized by orbital
inflammation and tissue remodeling. TED pathogenesis is poorly understood but is linked to …

Transcriptomic Profiling of Thyroid Eye Disease Orbital Fat Demonstrates Differences in Adipogenicity and IGF-1R Pathway

DW Kim, S Kim, J Han, K Belday, E Li, N Mahoney… - bioRxiv, 2024 - biorxiv.org
Despite recent advances in the treatment of thyroid eye disease (TED), significant gaps
remain in our understanding of the underlying molecular mechanisms, particularly …

Thyroid eye disease: From pathogenesis to targeted therapies

JS Yoon, DO Kikkawa - Taiwan Journal of Ophthalmology, 2022 - journals.lww.com
Thyroid eye disease (TED) is the most common extrathyroidal manifestation of autoimmune
Graves' hyperthyroidism. TED is a debilitating and potentially blinding disease with unclear …

Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy

Y Wang, TJ Smith - Investigative ophthalmology & visual …, 2014 - iovs.arvojournals.org
Graves' disease (GD) is a common autoimmune condition. At its core, stimulatory
autoantibodies are directed at the thyroid-stimulating hormone receptor (TSHR), resulting in …

Targeting TSH and IGF-1 receptors to treat thyroid eye disease

S Neumann, CC Krieger… - European Thyroid …, 2020 - etj.bioscientifica.com
Graves' disease (GD) is an autoimmune disease caused in part by thyroid-stimulating
antibodies (TSAbs) that activate the thyroid-stimulating hormone receptor (TSHR). In Graves' …

Immunopathogenesis of thyroid eye disease: emerging paradigms

VM Naik, MN Naik, RA Goldberg, TJ Smith… - Survey of …, 2010 - Elsevier
Graves disease represents a systemic autoimmune process targeting the thyroid, orbit, and
pretibial skin. The thyroid dysfunction is treatable, but no consistently effective medical …

Understanding the clinical and molecular basis of thyroid orbitopathy: a review of recent evidence

PD Nivean, N Madhivanan, G Kumaramanikavel… - Hormones, 2024 - Springer
Thyroid eye disease (TED) is an autoimmune orbital inflammatory disease which ranges
from mild to severe. Tissue remodeling, fibrosis and fat proliferation cause changes in the …

[HTML][HTML] Molecular biomarkers in thyroid eye disease: a literature review

HO Ueland, MT Neset, P Methlie… - Ophthalmic Plastic & …, 2023 - journals.lww.com
Purpose: Thyroid eye disease (TED) is the most common extrathyroidal manifestation of
Graves disease. Patients may be severely affected with eyelid retraction, exophthalmos …

40 YEARS OF IGF1: IGF1 receptor and thyroid-associated ophthalmopathy

M Mohyi, TJ Smith - Journal of molecular endocrinology, 2018 - jme.bioscientifica.com
Thyroid-associated ophthalmopathy (TAO) is a vexing and poorly understood autoimmune
process involving the upper face and tissues surrounding the eyes. In TAO, the orbit can …

Pathogenesis of thyroid eye disease: review and update on molecular mechanisms

JJ Khong, AA McNab, PR Ebeling, JE Craig… - British Journal of …, 2016 - bjo.bmj.com
Orbital changes in thyroid orbitopathy (TO) result from de novo adipogenesis, hyaluronan
synthesis, interstitial oedema and enlargement of extraocular muscles. Cellular immunity …